deltatrials
Active Not Recruiting OBSERVATIONAL NCT03221309

Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior (ANCHOR)

A Novel Model of Hepatitis C Treatment as Anchor to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior

Sponsor: University of Maryland, Baltimore

Conditions Buprenorphine HCV PreP
Interventions Evaluate model of care for HCV-infected adults with on-going opioid misuse
Updated 19 times since 2017 Last updated: Mar 7, 2025 Started: May 1, 2017 Primary completion: Jan 22, 2021 Completion: Jan 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03221309, this observational or N/A phase trial focuses on Buprenorphine and HCV and remains ongoing. Sponsored by University of Maryland, Baltimore, it has been updated 19 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Aug 2017 – ~Apr 2018 · 8 months · monthly snapshot~Apr 2018 – ~May 2018 · 30 days · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Sep 2019 · 12 months · monthly snapshot~Sep 2019 – ~Nov 2019 · 2 months · monthly snapshot~Nov 2019 – ~Nov 2020 · 12 months · monthly snapshot~Nov 2020 – ~Dec 2020 · 30 days · monthly snapshot~Dec 2020 – ~Jan 2021 · 31 days · monthly snapshot~Jan 2021 – ~May 2021 · 4 months · monthly snapshot~May 2021 – ~Dec 2021 · 7 months · monthly snapshot~Dec 2021 – ~Mar 2022 · 3 months · monthly snapshot~Mar 2022 – ~Nov 2022 · 8 months · monthly snapshot~Nov 2022 – ~Jul 2024 · 20 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2024 · 30 days · monthly snapshot~Oct 2024 – ~Apr 2025 · 6 months · monthly snapshot~Apr 2025 – ~Sep 2025 · 5 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

19 versions recorded

  1. Sep 2025 — Present [monthly]

    Active Not Recruiting

  2. Apr 2025 — Sep 2025 [monthly]

    Active Not Recruiting

  3. Oct 2024 — Apr 2025 [monthly]

    Active Not Recruiting

  4. Sep 2024 — Oct 2024 [monthly]

    Active Not Recruiting

  5. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

▶ Show 14 earlier versions

  1. Nov 2022 — Jul 2024 [monthly]

    Active Not Recruiting

  2. Mar 2022 — Nov 2022 [monthly]

    Active Not Recruiting

  3. Dec 2021 — Mar 2022 [monthly]

    Active Not Recruiting

  4. May 2021 — Dec 2021 [monthly]

    Active Not Recruiting

  5. Jan 2021 — May 2021 [monthly]

    Active Not Recruiting

  6. Dec 2020 — Jan 2021 [monthly]

    Active Not Recruiting

    Status: Enrolling By Invitation → Active Not Recruiting

  7. Nov 2020 — Dec 2020 [monthly]

    Enrolling By Invitation

  8. Nov 2019 — Nov 2020 [monthly]

    Enrolling By Invitation

  9. Sep 2019 — Nov 2019 [monthly]

    Enrolling By Invitation

  10. Sep 2018 — Sep 2019 [monthly]

    Enrolling By Invitation

  11. Jun 2018 — Sep 2018 [monthly]

    Enrolling By Invitation

  12. May 2018 — Jun 2018 [monthly]

    Enrolling By Invitation

  13. Apr 2018 — May 2018 [monthly]

    Enrolling By Invitation

    Phase: NA → None

  14. Aug 2017 — Apr 2018 [monthly]

    Enrolling By Invitation NA

    First recorded

May 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of Maryland, Baltimore
Data source: University of Maryland, Baltimore

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations